GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

近年来，国内外大量研究均已表明，HBV在肝内形成的共价闭合环状DNA（HBV cccDNA）库的持续存在与HBV慢性持续性感染以及慢性乙型肝炎（CHB）难以治愈密切相关。HBV cccDNA的彻底清除不仅是判定HBV感染彻底治愈的重要指标，也是终止CHB进展为肝硬化、肝细胞癌（HCC ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...

近年来，国内外大量研究均已表明，HBV在肝内形成的共价闭合环状DNA（HBV cccDNA）库的持续存在与HBV慢性持续性感染以及慢性乙型肝炎（CHB）难以治愈 ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Famciclovir. A prodrug of penciclovir, famciclovir does not have a major role in the treatment of chronic hepatitis B because of its low efficacy compared with lamivudine. Adefovir dipivoxil.

TAIPEI (Taiwan News) – Kaohsiung Medical University President Yu Ming-lung (余明隆) and South Korea's University of Ulsan College of Medicine Dean Lim Young-suk (林永錫) have found early antiviral treatment ...

A population-based, retrospective cohort study examining the risk of HCC and mortality in 1096 treated and 1096 matched untreated HCV/HBV dually infected patients. CI, confidence interval ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

and HBV DNA after 24 weeks' treatment to below the lower limit of detection in people with chronic hepatitis B, raising hopes that it could offer permanent cure, allowing safe termination of ...

Twenty-seven patients with Chronic Hepatitis B Virus infection (CHB) have now been dosed with VRON-0200 as a single (Prime), or Prime and Boost, intramuscular (i.m.) injection ...